• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的诊断与管理：2018年美国肝病研究学会指南的患者友好型总结

The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines.

作者信息

Bahirwani Ranjeeta, Griffin Connor

机构信息

Transplant Hepatology Hepatology Baylor University Medical Center at Dallas Dallas Texas USA.

Gastroenterology Baylor University Medical Center at Dallas Dallas Texas USA.

出版信息

Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):222-226. doi: 10.1002/cld.1216. eCollection 2022 Jun.

DOI:10.1002/cld.1216
PMID:35795618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9248926/
Abstract

Content available: Author Interview and Audio Recording.

摘要

提供的内容

作者访谈及音频记录。

相似文献

1
The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines.非酒精性脂肪性肝病的诊断与管理：2018年美国肝病研究学会指南的患者友好型总结
Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):222-226. doi: 10.1002/cld.1216. eCollection 2022 Jun.
2
Long-Term Management of the Successful Adult Liver Transplant: A Patient-Friendly Summary of the 2012 AASLD and AST Practice Guideline.成人肝移植成功后的长期管理：2012年美国肝病研究学会和美国移植学会实践指南的患者友好型概述
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):83-88. doi: 10.1002/cld.1179. eCollection 2022 Mar.
3
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病的转变
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):157-161. doi: 10.1002/cld.1250. eCollection 2022 Nov.
4
Diagnosis and management of chronic hepatitis B: A patient-friendly summary of the 2018 American Association for the Study of Liver Diseases practice guidance.慢性乙型肝炎的诊断与管理：2018年美国肝病研究协会实践指南的患者友好型总结
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):141-145. doi: 10.1002/cld.1240. eCollection 2022 Nov.
5
[An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].[2017年美国肝病研究学会非酒精性脂肪性肝病诊断和管理实践指南解读]
Zhonghua Gan Zang Bing Za Zhi. 2017 Sep 20;25(9):687-694. doi: 10.3760/cma.j.issn.1007-3418.2017.09.008.
6
Improvement in nonalcoholic fatty liver disease through bariatric surgery.通过减肥手术改善非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
7
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease.十二指肠黏膜重建治疗非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):166-169. doi: 10.1002/cld.1255. eCollection 2022 Nov.
8
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?间歇性禁食作为非酒精性脂肪性肝病的一种治疗方法：证据有哪些？
Clin Liver Dis (Hoboken). 2022 Feb 3;19(3):101-105. doi: 10.1002/cld.1172. eCollection 2022 Mar.
9
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会（INASL）关于非酒精性脂肪性肝病（NAFLD）命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
10
Liver Disease: Nonalcoholic Fatty Liver Disease.肝脏疾病：非酒精性脂肪性肝病。
FP Essent. 2021 Dec;511:29-35.

引用本文的文献

1
Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.心力衰竭与代谢功能障碍相关脂肪性肝病联合管理的指南导向性医学策略。
Commun Med (Lond). 2025 Jul 28;5(1):312. doi: 10.1038/s43856-025-00951-2.
2
INCIDENTAL HEPATIC STEATOSIS IDENTIFIED ON ULTRASOUND IN PATIENTS UNDERGOING CHOLECYSTECTOMY: HIGH PREVALENCE AND INSUFFICIENT INVESTIGATIVE AND CLINICAL MANAGEMENT.胆囊切除术患者超声检查发现的偶然肝脂肪变性：高患病率及调查和临床管理不足
Arq Gastroenterol. 2025 May 2;62:e24118. doi: 10.1590/S0004-2803.24612024-118. eCollection 2025.
3
Racial Differences in Liver Fibrosis Burden.肝纤维化负担的种族差异。
Dig Dis Sci. 2025 Mar 18. doi: 10.1007/s10620-025-08936-w.
4
The Effects of Testosterone Replacement Therapy in Adult Men With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis.睾酮替代疗法对患有代谢功能障碍相关脂肪性肝病成年男性的影响：一项系统评价和荟萃分析。
Clin Transl Gastroenterol. 2025 Jan 1;16(1):e00787. doi: 10.14309/ctg.0000000000000787.
5
Clinical cohort of nonalcoholic fatty liver disease in a primary care setting.基层医疗环境中非酒精性脂肪性肝病的临床队列
J Family Med Prim Care. 2024 Aug;13(8):2958-2963. doi: 10.4103/jfmpc.jfmpc_1769_23. Epub 2024 Jul 26.
6
The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review.熊去氧胆酸治疗非酒精性脂肪性肝病的治疗机制及有益作用：一项系统评价
Med Pharm Rep. 2024 Jan;97(1):12-25. doi: 10.15386/mpr-2629. Epub 2024 Jan 29.
7
Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review.解析胰岛素抵抗与非酒精性脂肪性肝病（或代谢功能障碍相关脂肪性肝病）之间的联系：一篇叙述性综述
J Diabetes Metab Disord. 2023 Sep 8;22(2):1083-1094. doi: 10.1007/s40200-023-01293-3. eCollection 2023 Dec.
8
Erratum.勘误
Clin Liver Dis (Hoboken). 2022 Dec 12;20(6):216. doi: 10.1002/cld.1257. eCollection 2022 Dec.

本文引用的文献

1
Preparing for the NASH Epidemic: A Call to Action.应对 NASH 流行：行动呼吁。
Diabetes Care. 2021 Sep;44(9):2162-2172. doi: 10.2337/dci21-0020. Epub 2021 Jul 26.
2
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.